Innoviva (INVA) EBIT Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.96% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -29.67% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -50.81% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.47% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -12.10% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 55.96% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 75.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.04% |
| Dec 31, 2025 | -10.20% |
| Sep 30, 2025 | 1,805.21% |
| Jun 30, 2025 | 93.88% |
| Mar 31, 2025 | 88.72% |
| Dec 31, 2024 | -20.34% |
| Sep 30, 2024 | -22.96% |
| Jun 30, 2024 | -17.26% |
| Mar 31, 2024 | -23.46% |
| Dec 31, 2023 | -0.64% |
| Sep 30, 2023 | 0.60% |
| Jun 30, 2023 | -28.61% |
| Mar 31, 2023 | -29.05% |
| Dec 31, 2022 | -28.87% |
| Sep 30, 2022 | -95.65% |
| Jun 30, 2022 | -29.15% |
| Mar 31, 2022 | -29.43% |
| Dec 31, 2021 | -27.62% |
| Sep 30, 2021 | 17.92% |
| Jun 30, 2021 | 15.49% |
| Mar 31, 2021 | -28.74% |
| Dec 31, 2020 | -28.00% |
| Sep 30, 2020 | 28.25% |
| Jun 30, 2020 | 16.58% |
| Mar 31, 2020 | 37.40% |
| Dec 31, 2019 | 25.05% |
| Sep 30, 2019 | 29.62% |
| Jun 30, 2019 | 32.18% |
| Mar 31, 2019 | 43.83% |
| Dec 31, 2018 | 64.67% |
| Sep 30, 2018 | 89.79% |
| Jun 30, 2018 | 130.65% |
| Mar 31, 2018 | 279.43% |
| Dec 31, 2017 | 699.39% |
| Sep 30, 2017 | 83.65% |
| Jun 30, 2017 | 90.23% |
| Mar 31, 2017 | 58.65% |
| Dec 31, 2016 | 92.00% |
| Sep 30, 2016 | 77.82% |
| Jun 30, 2016 | 79.17% |
| Mar 31, 2016 | 36.17% |
| Dec 31, 2015 | 34.08% |
| Sep 30, 2015 | 31.09% |
| Jun 30, 2015 | 28.93% |
| Mar 31, 2015 | -79.47% |
| Dec 31, 2014 | 26.07% |
| Sep 30, 2014 | 31.12% |
| Jun 30, 2014 | 25.47% |
| Mar 31, 2014 | 11.59% |
| Dec 31, 2013 | 25.49% |
| Sep 30, 2013 | 27.04% |
| Jun 30, 2013 | 29.19% |